Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Ovarian Research|March 26, 2024
TP63 truncating mutation causes increased cell apoptosis and premature ovarian insufficiency by enhanced transcriptional activation of CLCA2Yali Fan, Shuya Chen, Chunfang Chu, et al.
Annals of Clinical Microbiology and Antimicrobials|June 26, 2026
Clinical characteristics and temporal trends of meropenem and piperacillin/tazobactam heteroresistance in Pseudomonas aeruginosa isolatesYali Fan, Huilan Li, Xiaoyue Liang, et al.
Clinical and Experimental Medicine|July 8, 2025
Predicting SARS-CoV-2-specific CD4<sup>+</sup> and CD8<sup>+</sup> T-cell responses elicited by inactivated vaccines in healthy adults using machine learning modelsJie Ning, Yayi Ren, Zelin Zhang, et al.
ACS Nano|December 18, 2024
Utilizing Engineered Bacteria as "Cell Factories" <i>In Vivo</i> for Intracellular RNA-Loaded Outer Membrane Vesicles' Self-Assembly in Tumor TreatmentDawei Sun, Yize Li, Xiaoxuan Yin, et al.
American Journal of Cancer Research|July 11, 2022
Ipatasertib, an oral AKT inhibitor, inhibits cell proliferation and migration, and induces apoptosis in serous endometrial cancerLindsey Buckingham, Tianran Hao, Jillian O'Donnell, et al.
Biotechnology and Bioengineering|August 14, 2024
Sequential delivery of photosensitizers and checkpoint inhibitors by engineered bacteria for enhanced cancer photodynamic immunotherapyXinyu Liu, Yali Fan, Xinyu Zhang, et al.
Frontiers in Oncology|November 16, 2020
ONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer <i>In Vitro</i>Yingao Zhang, Yu Huang, Yajie Yin, et al.
American Journal of Translational Research|September 11, 2020
SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse modelsXiaoling Zhao, Weimin Kong, Katherine Tucker, et al.
Frontiers in Oncology|August 2, 2021
Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian CancerGuangxu Xu, Weimin Kong, Ziwei Fang, et al.
International Journal of Oncology|July 28, 2023
Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer <i>in vitro</i> and <i>in vivo</i>Jillian O'Donnell, Ziyi Zhao, Lindsey Buckingham, et al.
Pageof 7